Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |